BR112013016467A2 - composições e métodos para identificação e diferenciação de componentes do vírus das vacinas contra a febre dos transportes multivalentes - Google Patents

composições e métodos para identificação e diferenciação de componentes do vírus das vacinas contra a febre dos transportes multivalentes

Info

Publication number
BR112013016467A2
BR112013016467A2 BR112013016467A BR112013016467A BR112013016467A2 BR 112013016467 A2 BR112013016467 A2 BR 112013016467A2 BR 112013016467 A BR112013016467 A BR 112013016467A BR 112013016467 A BR112013016467 A BR 112013016467A BR 112013016467 A2 BR112013016467 A2 BR 112013016467A2
Authority
BR
Brazil
Prior art keywords
multivalent
differentiation
compositions
identification
methods
Prior art date
Application number
BR112013016467A
Other languages
English (en)
Portuguese (pt)
Inventor
Wade Weise Dale
Robert Harris James
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR112013016467A2 publication Critical patent/BR112013016467A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR112013016467A 2010-12-27 2011-12-21 composições e métodos para identificação e diferenciação de componentes do vírus das vacinas contra a febre dos transportes multivalentes BR112013016467A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061427404P 2010-12-27 2010-12-27
PCT/US2011/066392 WO2012092054A2 (en) 2010-12-27 2011-12-21 Compositions and methods for identifying and differentiating viral components of multivalent shipping fever vaccines

Publications (1)

Publication Number Publication Date
BR112013016467A2 true BR112013016467A2 (pt) 2018-09-18

Family

ID=45532015

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013016467A BR112013016467A2 (pt) 2010-12-27 2011-12-21 composições e métodos para identificação e diferenciação de componentes do vírus das vacinas contra a febre dos transportes multivalentes

Country Status (15)

Country Link
US (1) US9238843B2 (enExample)
EP (1) EP2659007B1 (enExample)
JP (1) JP6027023B2 (enExample)
CN (1) CN103403191B (enExample)
AR (1) AR084358A1 (enExample)
AU (1) AU2011352801B2 (enExample)
BR (1) BR112013016467A2 (enExample)
CA (1) CA2822798C (enExample)
ES (1) ES2613537T3 (enExample)
MX (1) MX348307B (enExample)
NZ (1) NZ611657A (enExample)
PL (1) PL2659007T3 (enExample)
PT (1) PT2659007T (enExample)
TW (1) TWI513821B (enExample)
WO (1) WO2012092054A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109563555A (zh) * 2016-05-06 2019-04-02 起源生物织物有限公司 培养的皮革及由其制作的产品
CN106906307A (zh) * 2017-03-10 2017-06-30 中国农业科学院特产研究所 牛副流感病毒3型病毒nano‑PCR检测试剂盒及其制备方法
CN113913461A (zh) * 2021-11-15 2022-01-11 贵州大学 牛病毒性腹泻e0-e2基因重组腺病毒疫苗构建方法
KR102827389B1 (ko) * 2021-12-03 2025-07-03 대한민국 소바이러스성설사 바이러스 유전아형 동시감별 진단 키트 및 진단방법
US12553093B1 (en) * 2025-03-26 2026-02-17 Wolf of Zion, Inc. Methods of detecting, identifying and quantifying wild spike protein and covid vaccine spike proteins

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
DE3329892A1 (de) 1983-08-18 1985-03-07 Köster, Hubert, Prof. Dr., 2000 Hamburg Verfahren zur herstellung von oligonucleotiden
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
FR2596761B1 (fr) 1986-04-08 1988-05-20 Commissariat Energie Atomique Derives de nucleosides et leur utilisation pour la synthese d'oligonucleotides
US4992051A (en) * 1987-11-03 1991-02-12 Novagene, Inc. Infectious bovine rhinotracheitis virus mutants, methods for the production of same and methods for the use of same
US5491225A (en) 1991-12-19 1996-02-13 Hoffmann-La Roche Inc. PCR primers for detection of legionella species and methods for controlling visual intensity in hybridization assays
US5279721A (en) 1993-04-22 1994-01-18 Peter Schmid Apparatus and method for an automated electrophoresis system
DE69518316T2 (de) 1994-05-10 2001-03-29 American Home Products Corp., Madison Modifizierter,verbesserter,lebender brsv impfstoff
FR2751229B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
EP1104676A1 (en) * 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
US20060084052A1 (en) * 2001-03-27 2006-04-20 Smithkline Beecham Corp. Detection of viable agents
EP1297110B1 (en) * 2000-06-23 2009-07-22 Intervet International BV Attenuated bovine respiratory syncytial virus
US20030124512A1 (en) * 2000-10-18 2003-07-03 Lieven Stuyver Simultaneous quantification of nucleic acids in diseased cells
EP1594537B1 (en) * 2003-02-19 2012-10-24 Merial Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3
BRPI0508941A (pt) 2004-03-17 2007-08-14 Pharmacia & Upjohn Co Llc método de vacinação contra infecção de bvdv testicular
US20090068223A1 (en) 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
EP2026839A4 (en) 2005-12-14 2009-04-01 Univ Oklahoma RNA VIRUS VACCINE AND METHODS
US8354514B2 (en) * 2007-01-12 2013-01-15 Lawrence Livermore National Security, Llc Multiplex detection of agricultural pathogens
CN101696453B (zh) * 2009-11-02 2012-01-25 东北农业大学 检测牛病毒性腹泻病毒逆转录环介导等温扩增反应试剂盒的制备方法
BR112013016503A2 (pt) * 2010-12-27 2018-05-22 Lilly Co Eli composições e método de vacina de vírus da diarreia viral bovina tipo 1b.

Also Published As

Publication number Publication date
NZ611657A (en) 2015-04-24
TW201307571A (zh) 2013-02-16
JP6027023B2 (ja) 2016-11-16
CA2822798C (en) 2016-11-01
MX2013007586A (es) 2013-10-17
CN103403191B (zh) 2016-05-18
EP2659007B1 (en) 2016-11-16
AU2011352801B2 (en) 2015-05-21
CA2822798A1 (en) 2012-07-05
PL2659007T3 (pl) 2017-08-31
US20130266934A1 (en) 2013-10-10
AU2011352801A1 (en) 2013-06-27
TWI513821B (zh) 2015-12-21
AR084358A1 (es) 2013-05-08
US9238843B2 (en) 2016-01-19
JP2014502846A (ja) 2014-02-06
WO2012092054A3 (en) 2012-12-27
MX348307B (es) 2017-06-06
CN103403191A (zh) 2013-11-20
PT2659007T (pt) 2017-01-18
EP2659007A2 (en) 2013-11-06
ES2613537T3 (es) 2017-05-24
WO2012092054A2 (en) 2012-07-05

Similar Documents

Publication Publication Date Title
IL262123A (en) Influenza virus vaccines and uses thereof
IL248607A (en) Methods and compositions for immunization against virus
IL232780A0 (en) Influenza virus vaccines and uses thereof
IL261204A (en) Influenza virus vaccines and their use
EP2552479A4 (en) INFLUENZA VIRUS VACCINES AND USES THEREOF
IL235137B (en) Compositions and methods comprising energy absorbing materials for follicular delivery
HUE042454T2 (hu) Berendezés zsír roncsolására és eltávolítására
HUE037325T2 (hu) Alumíniumvegyületek gyógyszerekben és vakcinákban történõ alkalmazásra
HUE045656T2 (hu) PHF-tau elleni ellenanyagok és alkalmazásuk
DK3170508T3 (da) Vaccineformuleringer
BR112013024493A2 (pt) cristais de anticorpo antiesclerostina e formulações dos mesmos
HUE038759T2 (hu) Terápiás nukleázkészítmények és eljárások
BR112014010658A2 (pt) antígenos e vacinas direcionadas contra enterovírus humano
BR112013013040A2 (pt) cápsula e método para preparação de bebida por centrifugação
EP2753364A4 (en) CONDITIONS REPLICATED CYTOMEGALOVIRUS AS VACCINE AGAINST CMV
DK2547770T3 (da) Levende svækket kimær porcint circovirusvaccine
HUE037664T2 (hu) Állati takarmány és eljárás annak elõállítására
BR112013007486A2 (pt) vacinas de herpesvírus vetorizadas com vírus da doença de newcastle
PT2580240T (pt) Anticorpos as100a4 e utilizações terapêuticas dos mesmos
HUE049217T2 (hu) Szövetkárosodás és fibrózis enyhítése LTBP4 elleni ellenanyaggal
CO6870003A2 (es) Vacunas bovinas y métodos
PT2579901T (pt) Vacina e métodos para reduzir infeção por campylobacter
EP2755680A4 (en) PARTICULATE VACCINE FORMULATIONS
EP2825196A4 (en) ADJUVANZ AND VACCINE COMPOSITIONS
EP2640417A4 (en) MULTIVALENCE VACCINE AGAINST FILARIOSIS

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: ELANCO US INC. (US)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]